Roche Archives - NeuroNews International

Tenecteplase becomes first new stroke medicine to gain Health Canada approval...

19 December 2025

Hoffmann-La Roche (Roche Canada) announced this week that Health Canada has granted market authorisation for its TNKase brand of tenecteplase—a thrombolytic agent—in the treatment...

Write to us
Editor: Jamie Bell [email protected]
Advertising: Abbie Richardson [email protected]

United Kingdom:

BIBA Medical, Europe
526 Fulham Road, Fulham, London, SW6 5NR
TEL: +44 (0)20 7736 8788
Email: [email protected]

United States:

BIBA Medical, North America
155 North Wacker Drive, Suite 4250, Chicago, IL 60606
TEL: +1 949 723 9309
Email: [email protected]

Terms and Conditions | Privacy Policy

Tag: Roche

Tenecteplase becomes first new stroke medicine to gain Health Canada approval...